The diabetes management app developer raised $40m in a round led by Bayer, which has also signed a licensing agreement with the company.

Riverain Technologies raised the cash in a round led by Ping An Global Voyager Fund and will use the cash to expands its lung cancer diagnostics technology.

The cancer care platform developer secured funding in a series D round co-led by Merck Global Health Innovation Fund and backed by LabCorp.

Lilly Asia Ventures has returned for the genomic drug developer's latest round, having already taken part in a $15m pre-series B round just over a year ago.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

A new $10.4m vehicle targeting South Africa's university ecosystem is due to be approved on September 28.

The Visegrad Fund has been pumping money into driving innovation and entrepreneurship across Czech Republic, Hungary, Poland and Slovakia.

Lundbeck, Pfizer and Alexandria Real Estate Equities are all in line for exits after Imara revealed it has confidentially filed for an initial public offering.

The developing digital health sector has had to wait almost three years for the public markets to open up to it, but when they did, it was corporate venturing portfolio companies that were first through the flotation exit doors.

Cambridge Innovation Capital has returned a second time to back a $240m series C for CMR Surgical, helping bring the surgical robotics company's total funding to $386m.